MBK-01

N/A

Report date: 2022/11/05 14:23:24

Base Information

Drug NameMBK-01
Drug Alias NameMBK-01
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseDiverticulitis, ColonicDiverticulitis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMikrobiomik Healthcare Company SL
China Registration ClassN/A

Develop Information

Active CompaniesInstituto De Investigación Marqués De ValdecillaMikrobiomik Healthcare Company SL
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseDiverticulitis, ColonicDiverticulitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A